Id |
Subject |
Object |
Predicate |
Lexical cue |
T79 |
0-61 |
Sentence |
denotes |
The demographics of the study cohort are detailed in Table 1. |
T80 |
62-187 |
Sentence |
denotes |
Patients with exposure history (recent travel to Wuhan or contact with infected patient) accounted for 85.2% of study cohort. |
T81 |
188-261 |
Sentence |
denotes |
Fever (84.1%) and cough (56.8%) were the most common presenting symptoms. |
T82 |
262-409 |
Sentence |
denotes |
Low lymphocyte and white cell counts were observed in 26.4% and 25.0% of patients, while high C-reactive protein was observed in 55.0% of patients. |
T83 |
410-466 |
Sentence |
denotes |
Table 1 Patient demographics and laboratory test results |
T84 |
467-507 |
Sentence |
denotes |
Characteristic Patient with NCP (n = 88) |
T85 |
508-532 |
Sentence |
denotes |
Age (years)a 42.7 ± 14.5 |
T86 |
533-550 |
Sentence |
denotes |
Age group (years) |
T87 |
551-565 |
Sentence |
denotes |
< 15 2 (2.3) |
T88 |
566-583 |
Sentence |
denotes |
15–44 48 (54.5) |
T89 |
584-601 |
Sentence |
denotes |
45–64 28 (31.8) |
T90 |
602-618 |
Sentence |
denotes |
≥ 65 10 (11.4) |
T91 |
619-637 |
Sentence |
denotes |
Male sex 51 (58.0) |
T92 |
638-654 |
Sentence |
denotes |
Exposure history |
T93 |
655-689 |
Sentence |
denotes |
Recent travel to Wuhan 45 (51.1) |
T94 |
690-731 |
Sentence |
denotes |
Contact with infected patient 30 (34.1) |
T95 |
732-760 |
Sentence |
denotes |
Unknown exposure 13 (14.8) |
T96 |
761-777 |
Sentence |
denotes |
Initial symptoms |
T97 |
778-795 |
Sentence |
denotes |
Fever 74 (84.1) |
T98 |
796-813 |
Sentence |
denotes |
Cough 50 (56.8) |
T99 |
814-839 |
Sentence |
denotes |
Expectoration 19 (21.6) |
T100 |
840-859 |
Sentence |
denotes |
Fatigue 15 (17.0) |
T101 |
860-913 |
Sentence |
denotes |
Chest distress and/or shortness of breath 12 (13.6) |
T102 |
914-938 |
Sentence |
denotes |
Pharyngalgia 10 (11.4) |
T103 |
939-964 |
Sentence |
denotes |
Muscle soreness 7 (8.0) |
T104 |
965-983 |
Sentence |
denotes |
Headache 5 (5.7) |
T105 |
984-1014 |
Sentence |
denotes |
Nausea and/or vomiting 0 (0) |
T106 |
1015-1031 |
Sentence |
denotes |
Diarrhea 0 (0) |
T107 |
1032-1061 |
Sentence |
denotes |
No obvious symptoms 3 (3.4) |
T108 |
1062-1107 |
Sentence |
denotes |
Laboratory testing at initial hospital visitb |
T109 |
1108-1172 |
Sentence |
denotes |
White blood cell count (–, ↑, ↓) 62 (70.5), 4 (4.5), 22 (25.0) |
T110 |
1173-1231 |
Sentence |
denotes |
Lymphocyte count (–, ↑, ↓) 62 (71.3), 2 (2.3), 23 (26.4) |
T111 |
1232-1293 |
Sentence |
denotes |
Percent lymphocytes (–, ↑, ↓) 55 (62.5), 7 (8.0), 26 (29.5) |
T112 |
1294-1370 |
Sentence |
denotes |
Percent neutrophilic granulocyte (–, ↑, ↓) 59 (67.1), 17 (19.3), 12 (13.6) |
T113 |
1371-1430 |
Sentence |
denotes |
Percent monocytes (–, ↑, ↓) 59 (67.1), 26 (29.5), 3 (3.4) |
T114 |
1431-1483 |
Sentence |
denotes |
Hemoglobin (–, ↑, ↓) 68 (77.3), 8 (9.1), 12 (13.6) |
T115 |
1484-1529 |
Sentence |
denotes |
ALT (–, ↑, ↓) 70 (79.5), 16 (18.2), 2 (2.3) |
T116 |
1530-1573 |
Sentence |
denotes |
AST (–, ↑, ↓) 73 (83.0), 15 (17.0), 0 (0) |
T117 |
1574-1630 |
Sentence |
denotes |
Creatine kinase (–, ↑, ↓) 73 (84.9), 4 (4.6), 9 (10.5) |
T118 |
1631-1689 |
Sentence |
denotes |
C-reactive protein (–, ↑, ↓) 36 (45.0), 44 (55.0), 0 (0) |
T119 |
1690-1794 |
Sentence |
denotes |
Unless otherwise indicated, data are reported as the number of patients, with percentages in parentheses |
T120 |
1795-1855 |
Sentence |
denotes |
ALT alanine aminotransferase, AST aspartate aminotransferase |
T121 |
1856-1908 |
Sentence |
denotes |
aData are reported as the mean ± standard derivation |
T122 |
1909-2017 |
Sentence |
denotes |
bThe signs –, ↑, and ↓ represent within, above, and below normal ranges of laboratory results, respectively. |
T123 |
2018-2354 |
Sentence |
denotes |
Normal ranges of white blood cell count, lymphocyte count, percent lymphocytes, percent neutrophilic granulocyte, percent monocytes, ALT, AST, creatine kinase, hemoglobin, and C-reactive protein were 3.5–9.5 × 109/L, 1.10–3.20 × 109/L, 20–50%, 3.0–10.0%, 40–75%, 115–150 g/L, 7–40 U/L, 13–35 U/L, 40–200 U/L, and 0–10 mg/L, respectively |